NanoLogix Announces Commercial Collaboration With Advanced Medical German Company of Kuwait
20 December 2010 - 11:30PM
Business Wire
NanoLogix (OTC MARKETS: NNLX), an innovator in the accelerated
detection and identification of microorganisms, is pleased to
announce its collaboration with Advanced Medical German Company of
Kuwait (AMGKWT). This alliance will support NanoLogix’s market
penetration goals for the Middle East, North and East Africa with
the international marketing focus of Advanced Medical German
Company stretching from the Middle East through Africa.
“This collaboration with NanoLogix reinforces our commitment to
providing exceptional and innovative health care solutions,” said
Dr. Eyad Al Saleh, MD, President and CEO of Advanced Medical German
Company. “We are pleased to work with NanoLogix, whose technologies
enhance our mission to meet growing laboratory demand for faster
test results and reduced testing costs.”
“We are confident this association with Advanced Medical German
Company marks a new chapter in our company evolution,” said
NanoLogix CEO Bret Barnhizer. “This endeavor complements our
ongoing work with the University of Texas Health Science Center -
Houston, The US EPA and others. It supports our goal of
international market entry and provides access for our technology
to important life science markets in the Middle East and Africa,
with a regional population of over 700 million. In addition to
marketing, sales and production operations through AMGKWT, we look
forward to their assistance as required with certification and
validation of our rapid detection and identification
technologies.”
Contact between NanoLogix and Advanced Medical German Company
was initiated in 2009 and advanced in 2010 with a visit to Kuwait
and Dubai by NanoLogix CEO Bret Barnhizer and Director John
Chatterton.
CEO Barnhizer plans to attend Arab Health 2011, the world's
second-largest medical exhibition, in Dubai January 24 - 27, where
AMGKWT will be an exhibitor. For information on Arab Health 2011:
http://www.arabhealthonline.com/Event-Info/About-Arab-Health/
About Advanced Medical German Company
The Advanced Medical German Company provides complete,
cost-effective, quality assured health care services through
pioneering life science, medical, pharmaceutical departments and
laboratories. The company deals with products and services for
early detection, prevention, and diagnosis, as well as drugs for
the treatment of diseases. AMGKWT provides products and services
tailored to the needs of a wide range of organizations, doctors and
patient groups.
Information on Advanced Medical German Company is available at:
www.amgkwt.com
About NanoLogix, Inc.
NanoLogix is a biotechnology company focused primarily on rapid
diagnostics. Its products offer accelerated detection and
identification of microorganisms. In addition to medical and
homeland security applications, NanoLogix technology is applicable
in pharmaceutical, industrial, veterinary and environmental
testing. Patents granted to NanoLogix can be used in the areas of
applied microbiology, soil microbiology and bioremediation,
microbial physiology, molecular biology, pharmacology,
pharmaco-kinetics, and antibiotic sensitivity.
For more information visit www.nanologix.com.
This press release contains statements, which may constitute
"forward- looking statements" within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Those
statements include statements regarding the intent, belief or
current expectations of NanoLogix, Inc., and members of its
management as well as the assumptions on which such statements are
based. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, and that actual results may
differ materially from those contemplated by such forward-looking
statements. The Company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results.
NanoLogix (CE) (USOTC:NNLX)
Historical Stock Chart
From Jun 2024 to Jul 2024
NanoLogix (CE) (USOTC:NNLX)
Historical Stock Chart
From Jul 2023 to Jul 2024